Susquehanna International Group’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,000
Closed -$103K 12237
2023
Q4
$103K Hold
36,000
﹤0.01% 11309
2023
Q3
$93.2K Hold
36,000
﹤0.01% 10977
2023
Q2
$144K Buy
+36,000
New +$157K ﹤0.01% 10615
2023
Q1
Sell
-2,579
Closed -$18.1K 12618
2022
Q4
$18.1K Hold
2,579
﹤0.01% 11794
2022
Q3
$34K Hold
2,579
﹤0.01% 12407
2022
Q2
$39K Sell
2,579
-2,571
-50% -$35.1K ﹤0.01% 12104
2022
Q1
$89K Sell
5,150
-2,393
-32% -$45.6K ﹤0.01% 11984
2021
Q4
$193K Sell
7,543
-36
-0.5% -$1.4K ﹤0.01% 11484
2021
Q3
$352K Buy
7,579
+1,708
+29% +$96K ﹤0.01% 10231
2021
Q2
$446K Buy
+5,871
New +$385K ﹤0.01% 9856

Other funds holding CALC

Susquehanna International Group's CALC Position: Q1 2026 in Review

Susquehanna International Group opened a new position in CalciMedica (CALC) in Q1 2026: 30,716 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #12888 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in CALC as recently as Q4 2022.

Susquehanna International Group first reported a position in CALC in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.46M in Q2 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Susquehanna International Group held 30,716 shares of CalciMedica worth $16.6K as of Q1 2026.
  • CalciMedica was a new Susquehanna International Group position in Q1 2026.
  • CalciMedica made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12888 holding.
  • Susquehanna International Group first reported a position in CalciMedica in Q2 2021 and has held it in 6 quarters since.
  • Susquehanna International Group's CalciMedica position peaked at $1.46M in Q2 2021.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.